Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Cipla
Farmers Insurance
McKesson
US Department of Justice
Dow
Cantor Fitzgerald
Fuji
Federal Trade Commission

Generated: July 21, 2018

DrugPatentWatch Database Preview

Betamethasone dipropionate - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for betamethasone dipropionate and what is the scope of betamethasone dipropionate patent protection?

Betamethasone dipropionate
is the generic ingredient in eleven branded drugs marketed by Fougera Pharms, Glenmark Generics, Perrigo New York, Taro, Tolmar, Schering, Merck Sharp Dohme, Savage Labs, Actavis Mid Atlantic, Pharmaderm, Teva, Teligent Pharma Inc, Alpharma Us Pharms, Fougera Pharms Inc, G And W Labs Inc, Hi-tech Pharmacal, Promius Pharma Llc, Leo Pharma As, Perrigo Israel, and Glenmark Pharms, and is included in sixty-three NDAs. There are nine patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Betamethasone dipropionate has seven patent family members in five countries.

There are sixty-six drug master file entries for betamethasone dipropionate. Twenty suppliers are listed for this compound.
Pharmacology for betamethasone dipropionate

US Patents and Regulatory Information for betamethasone dipropionate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmaderm BETAMETHASONE DIPROPIONATE betamethasone dipropionate LOTION;TOPICAL 070274-001 Aug 12, 1985 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Glenmark Generics BETAMETHASONE DIPROPIONATE betamethasone dipropionate CREAM, AUGMENTED;TOPICAL 078930-001 Sep 23, 2008 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Schering DIPROSONE betamethasone dipropionate DISC;TOPICAL 017829-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Taro BETAMETHASONE DIPROPIONATE betamethasone dipropionate LOTION;TOPICAL 072276-001 Aug 24, 1988 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for betamethasone dipropionate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck Sharp Dohme DIPROLENE betamethasone dipropionate LOTION, AUGMENTED;TOPICAL 019716-001 Aug 1, 1988 ➤ Sign Up ➤ Sign Up
Merck Sharp Dohme DIPROLENE betamethasone dipropionate OINTMENT, AUGMENTED;TOPICAL 018741-001 Jul 27, 1983 ➤ Sign Up ➤ Sign Up
Schering DIPROLENE betamethasone dipropionate CREAM, AUGMENTED;TOPICAL 019408-001 Jan 31, 1986 ➤ Sign Up ➤ Sign Up
Merck Sharp Dohme DIPROLENE AF betamethasone dipropionate CREAM, AUGMENTED;TOPICAL 019555-001 Apr 27, 1987 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Queensland Health
Deloitte
Baxter
Cipla
Teva
Dow
AstraZeneca
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.